Employing Dox-inducible POSTN knockdown in SCLC and NOTCH1 functional inhibitor DAPT in fibroblasts effectively improved the anti-tumor efficacy, offering a novel therapeutic strategy to impede SCLC liver metastasis. This evidence concerns the gene POSTN and small cell lung carcinoma.